InsidersTradesSigma
Track the 오리엔트바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has logged 8 insider filings. The latest transaction was disclosed on 8 July 2026 (Other). Among the most active insiders: 오리엔트. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
Orient Bio is a company specializing in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development and distribution of biopharmaceutical products.